APO Research
Talk to an analyst

APO RESEARCH · REPORT

Type 1 Diabetes (T1D)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Type 1 Diabetes (T1D) Industry Growth and Trends Forecast to 2032

22 December 2025106 pages

Choose your research edition.

Industry ResearchType 1 Diabetes (T1D) Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Type 1 Diabetes (T1D) Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Type 1 Diabetes (T1D) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Type 1 Diabetes (T1D) Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Type 1 Diabetes (T1D) Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Type 1 Diabetes (T1D) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Type 1 Diabetes (T1D) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Type 1 Diabetes (T1D) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Type 1 Diabetes (T1D) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Type 1 Diabetes (T1D) include Janssen, Sanofi, Sanofi, Novo Nordisk, Merck, Eli Lilly, Samsung Bioepis, Lexicon and Bristol-Myers Squibb, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Type 1 Diabetes (T1D) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Type 1 Diabetes (T1D) market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Type 1 Diabetes (T1D) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Type 1 Diabetes (T1D).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Type 1 Diabetes (T1D) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Type 1 Diabetes (T1D) Market by Company

Janssen

Sanofi

Sanofi

Novo Nordisk

Merck

Eli Lilly

Samsung Bioepis

Lexicon

Bristol-Myers Squibb

Boehringer Ingelheim

Biocon

Astellas

Type 1 Diabetes (T1D) Segment by Type

Long Acting Insulin Analogs

Premix Insulin Analogs

Rapid Acting Insulin Analogs

Type 1 Diabetes (T1D) Segment by Application

Children

Adults

Type 1 Diabetes (T1D) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Type 1 Diabetes (T1D) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Type 1 Diabetes (T1D) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Type 1 Diabetes (T1D).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Type 1 Diabetes (T1D) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Type 1 Diabetes (T1D) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Long Acting Insulin Analogs Table 2. Major Company of Premix Insulin Analogs Table 3. Major Company of Rapid Acting Insulin Analogs Table 4. Global Type 1 Diabetes (T1D) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Type 1 Diabetes (T1D) Sales by Type (2021-2026) & (k units) Table 6. Global Type 1 Diabetes (T1D) Sales Market Share in Volume by Type (2021-2026) Table 7. Global Type 1 Diabetes (T1D) Sales by Type (2021-2026) & (US$ Million) Table 8. Global Type 1 Diabetes (T1D) Sales Market Share in Value by Type (2021-2026) Table 9. Global Type 1 Diabetes (T1D) Price by Type (2021-2026) & (US$/unit) Table 10. Global Type 1 Diabetes (T1D) Sales by Type (2027-2032) & (k units) Table 11. Global Type 1 Diabetes (T1D) Sales Market Share in Volume by Type (2027-2032) Table 12. Global Type 1 Diabetes (T1D) Sales by Type (2027-2032) & (US$ Million) Table 13. Global Type 1 Diabetes (T1D) Sales Market Share in Value by Type (2027-2032) Table 14. Global Type 1 Diabetes (T1D) Price by Type (2027-2032) & (US$/unit) Table 15. North America Type 1 Diabetes (T1D) Sales by Type (2021-2026) & (k units) Table 16. North America Type 1 Diabetes (T1D) Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Type 1 Diabetes (T1D) Sales by Type (2021-2026) & (k units) Table 18. Europe Type 1 Diabetes (T1D) Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Type 1 Diabetes (T1D) Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Type 1 Diabetes (T1D) Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Type 1 Diabetes (T1D) Sales by Type (2021-2026) & (k units) Table 22. Latin America Type 1 Diabetes (T1D) Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Type 1 Diabetes (T1D) Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Type 1 Diabetes (T1D) Sales by Type (2021-2026) & (US$ Million) Table 25. Type 1 Diabetes (T1D) Industry Trends Table 26. Type 1 Diabetes (T1D) Industry Drivers Table 27. Type 1 Diabetes (T1D) Industry Opportunities and Challenges Table 28. Type 1 Diabetes (T1D) Industry Restraints Table 29. Global Type 1 Diabetes (T1D) Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Type 1 Diabetes (T1D) Revenue Market Share by Company (2021-2026) Table 31. Global Type 1 Diabetes (T1D) Sales by Company (2021-2026) & (k units) Table 32. Global Type 1 Diabetes (T1D) Sales Share by Company (2021-2026) Table 33. Global Type 1 Diabetes (T1D) Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Type 1 Diabetes (T1D) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Type 1 Diabetes (T1D) Major Company Production Sites and Headquarters Table 36. Global Type 1 Diabetes (T1D) Company, Product Type & Application Table 37. Global Type 1 Diabetes (T1D) Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Type 1 Diabetes (T1D) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Type 1 Diabetes (T1D) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Type 1 Diabetes (T1D) Sales by Region (2021-2026) & (k units) Table 42. Global Type 1 Diabetes (T1D) Sales Market Share in Volume by Region (2021-2026) Table 43. Global Type 1 Diabetes (T1D) Sales by Region (2021-2026) & (US$ Million) Table 44. Global Type 1 Diabetes (T1D) Sales Market Share in Value by Region (2021-2026) Table 45. Global Type 1 Diabetes (T1D) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Type 1 Diabetes (T1D) Sales by Region (2027-2032) & (k units) Table 47. Global Type 1 Diabetes (T1D) Sales Market Share in Volume by Region (2027-2032) Table 48. Global Type 1 Diabetes (T1D) Sales by Region (2027-2032) & (US$ Million) Table 49. Global Type 1 Diabetes (T1D) Sales Market Share in Value by Region (2027-2032) Table 50. Global Type 1 Diabetes (T1D) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Type 1 Diabetes (T1D) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Type 1 Diabetes (T1D) Sales by Application (2021-2026) & (k units) Table 53. Global Type 1 Diabetes (T1D) Sales Market Share in Volume by Application (2021-2026) Table 54. Global Type 1 Diabetes (T1D) Sales by Application (2021-2026) & (US$ Million) Table 55. Global Type 1 Diabetes (T1D) Sales Market Share in Value by Application (2021-2026) Table 56. Global Type 1 Diabetes (T1D) Price by Application (2021-2026) & (US$/unit) Table 57. Global Type 1 Diabetes (T1D) Sales by Application (2027-2032) & (k units) Table 58. Global Type 1 Diabetes (T1D) Sales Market Share in Volume by Application (2027-2032) Table 59. Global Type 1 Diabetes (T1D) Sales by Application (2027-2032) & (US$ Million) Table 60. Global Type 1 Diabetes (T1D) Sales Market Share in Value by Application (2027-2032) Table 61. Global Type 1 Diabetes (T1D) Price by Application (2027-2032) & (US$/unit) Table 62. North America Type 1 Diabetes (T1D) Sales by Application (2021-2026) & (k units) Table 63. North America Type 1 Diabetes (T1D) Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Type 1 Diabetes (T1D) Sales by Application (2021-2026) & (k units) Table 65. Europe Type 1 Diabetes (T1D) Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Type 1 Diabetes (T1D) Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Type 1 Diabetes (T1D) Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Type 1 Diabetes (T1D) Sales by Application (2021-2026) & (k units) Table 69. Latin America Type 1 Diabetes (T1D) Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Type 1 Diabetes (T1D) Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Type 1 Diabetes (T1D) Sales by Application (2021-2026) & (US$ Million) Table 72. Janssen Company Information Table 73. Janssen Business Overview Table 74. Janssen Type 1 Diabetes (T1D) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Janssen Type 1 Diabetes (T1D) Product Portfolio Table 76. Janssen Recent Development Table 77. Sanofi Company Information Table 78. Sanofi Business Overview Table 79. Sanofi Type 1 Diabetes (T1D) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Sanofi Type 1 Diabetes (T1D) Product Portfolio Table 81. Sanofi Recent Development Table 82. Sanofi Company Information Table 83. Sanofi Business Overview Table 84. Sanofi Type 1 Diabetes (T1D) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Sanofi Type 1 Diabetes (T1D) Product Portfolio Table 86. Sanofi Recent Development Table 87. Novo Nordisk Company Information Table 88. Novo Nordisk Business Overview Table 89. Novo Nordisk Type 1 Diabetes (T1D) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Novo Nordisk Type 1 Diabetes (T1D) Product Portfolio Table 91. Novo Nordisk Recent Development Table 92. Merck Company Information Table 93. Merck Business Overview Table 94. Merck Type 1 Diabetes (T1D) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Merck Type 1 Diabetes (T1D) Product Portfolio Table 96. Merck Recent Development Table 97. Eli Lilly Company Information Table 98. Eli Lilly Business Overview Table 99. Eli Lilly Type 1 Diabetes (T1D) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Eli Lilly Type 1 Diabetes (T1D) Product Portfolio Table 101. Eli Lilly Recent Development Table 102. Samsung Bioepis Company Information Table 103. Samsung Bioepis Business Overview Table 104. Samsung Bioepis Type 1 Diabetes (T1D) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Samsung Bioepis Type 1 Diabetes (T1D) Product Portfolio Table 106. Samsung Bioepis Recent Development Table 107. Lexicon Company Information Table 108. Lexicon Business Overview Table 109. Lexicon Type 1 Diabetes (T1D) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Lexicon Type 1 Diabetes (T1D) Product Portfolio Table 111. Lexicon Recent Development Table 112. Bristol-Myers Squibb Company Information Table 113. Bristol-Myers Squibb Business Overview Table 114. Bristol-Myers Squibb Type 1 Diabetes (T1D) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Bristol-Myers Squibb Type 1 Diabetes (T1D) Product Portfolio Table 116. Bristol-Myers Squibb Recent Development Table 117. Boehringer Ingelheim Company Information Table 118. Boehringer Ingelheim Business Overview Table 119. Boehringer Ingelheim Type 1 Diabetes (T1D) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Boehringer Ingelheim Type 1 Diabetes (T1D) Product Portfolio Table 121. Boehringer Ingelheim Recent Development Table 122. Biocon Company Information Table 123. Biocon Business Overview Table 124. Biocon Type 1 Diabetes (T1D) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Biocon Type 1 Diabetes (T1D) Product Portfolio Table 126. Biocon Recent Development Table 127. Astellas Company Information Table 128. Astellas Business Overview Table 129. Astellas Type 1 Diabetes (T1D) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. Astellas Type 1 Diabetes (T1D) Product Portfolio Table 131. Astellas Recent Development Table 132. North America Type 1 Diabetes (T1D) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 133. North America Type 1 Diabetes (T1D) Sales by Country (2021-2026) & (k units) Table 134. North America Type 1 Diabetes (T1D) Sales Market Share by Country (2021-2026) Table 135. North America Type 1 Diabetes (T1D) Sales Forecast by Country (2027-2032) & (k units) Table 136. North America Type 1 Diabetes (T1D) Sales Market Share Forecast by Country (2027-2032) Table 137. North America Type 1 Diabetes (T1D) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. North America Type 1 Diabetes (T1D) Market Size by Country (2021-2026) & (US$ Million) Table 139. North America Type 1 Diabetes (T1D) Market Share by Country (2021-2026) Table 140. North America Type 1 Diabetes (T1D) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. North America Type 1 Diabetes (T1D) Market Share Forecast by Country (2027-2032) Table 142. Europe Type 1 Diabetes (T1D) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 143. Europe Type 1 Diabetes (T1D) Sales by Country (2021-2026) & (k units) Table 144. Europe Type 1 Diabetes (T1D) Sales Market Share by Country (2021-2026) Table 145. Europe Type 1 Diabetes (T1D) Sales Forecast by Country (2027-2032) & (k units) Table 146. Europe Type 1 Diabetes (T1D) Sales Market Share Forecast by Country (2027-2032) Table 147. Europe Type 1 Diabetes (T1D) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Europe Type 1 Diabetes (T1D) Market Size by Country (2021-2026) & (US$ Million) Table 149. Europe Type 1 Diabetes (T1D) Market Share by Country (2021-2026) Table 150. Europe Type 1 Diabetes (T1D) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Europe Type 1 Diabetes (T1D) Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Type 1 Diabetes (T1D) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Type 1 Diabetes (T1D) Sales by Country (2021-2026) & (k units) Table 154. Asia-Pacific Type 1 Diabetes (T1D) Sales Market Share by Country (2021-2026) Table 155. Asia-Pacific Type 1 Diabetes (T1D) Sales Forecast by Country (2027-2032) & (k units) Table 156. Asia-Pacific Type 1 Diabetes (T1D) Sales Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Type 1 Diabetes (T1D) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Type 1 Diabetes (T1D) Market Size by Country (2021-2026) & (US$ Million) Table 159. Asia-Pacific Type 1 Diabetes (T1D) Market Share by Country (2021-2026) Table 160. Asia-Pacific Type 1 Diabetes (T1D) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Asia-Pacific Type 1 Diabetes (T1D) Market Share Forecast by Country (2027-2032) Table 162. Latin America Type 1 Diabetes (T1D) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 163. Latin America Type 1 Diabetes (T1D) Sales by Country (2021-2026) & (k units) Table 164. Latin America Type 1 Diabetes (T1D) Sales Market Share by Country (2021-2026) Table 165. Latin America Type 1 Diabetes (T1D) Sales Forecast by Country (2027-2032) & (k units) Table 166. Latin America Type 1 Diabetes (T1D) Sales Market Share Forecast by Country (2027-2032) Table 167. Latin America Type 1 Diabetes (T1D) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Latin America Type 1 Diabetes (T1D) Market Size by Country (2021-2026) & (US$ Million) Table 169. Latin America Type 1 Diabetes (T1D) Market Share by Country (2021-2026) Table 170. Latin America Type 1 Diabetes (T1D) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Latin America Type 1 Diabetes (T1D) Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Type 1 Diabetes (T1D) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Type 1 Diabetes (T1D) Sales by Country (2021-2026) & (k units) Table 174. Middle East and Africa Type 1 Diabetes (T1D) Sales Market Share by Country (2021-2026) Table 175. Middle East and Africa Type 1 Diabetes (T1D) Sales Forecast by Country (2027-2032) & (k units) Table 176. Middle East and Africa Type 1 Diabetes (T1D) Sales Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Type 1 Diabetes (T1D) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Type 1 Diabetes (T1D) Market Size by Country (2021-2026) & (US$ Million) Table 179. Middle East and Africa Type 1 Diabetes (T1D) Market Share by Country (2021-2026) Table 180. Middle East and Africa Type 1 Diabetes (T1D) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Middle East and Africa Type 1 Diabetes (T1D) Market Share Forecast by Country (2027-2032) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Type 1 Diabetes (T1D) Distributors List Table 185. Type 1 Diabetes (T1D) Customers List Table 186. Research Programs/Design for This Report Table 187. Authors List of This Report Table 188. Secondary Sources Table 189. Primary Sources List of Figures Figure 1. Type 1 Diabetes (T1D) Image Figure 2. Global Type 1 Diabetes (T1D) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Type 1 Diabetes (T1D) Market Size (2021-2032) & (US$ Million) Figure 4. Global Type 1 Diabetes (T1D) Sales (2021-2032) & (k units) Figure 5. Long Acting Insulin Analogs Image Figure 6. Global Long Acting Insulin Analogs Sales YoY Growth (2021-2032) & (k units) Figure 7. Premix Insulin Analogs Image Figure 8. Global Premix Insulin Analogs Sales YoY Growth (2021-2032) & (k units) Figure 9. Rapid Acting Insulin Analogs Image Figure 10. Global Rapid Acting Insulin Analogs Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Type 1 Diabetes (T1D) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Type 1 Diabetes (T1D) Market Share by Type 2025 VS 2032 Figure 13. North America Type 1 Diabetes (T1D) Sales Market Share in Volume by Type in 2025 Figure 14. North America Type 1 Diabetes (T1D) Sales Market Share in Value by Type in 2025 Figure 15. Europe Type 1 Diabetes (T1D) Sales Market Share in Volume by Type in 2025 Figure 16. Europe Type 1 Diabetes (T1D) Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Type 1 Diabetes (T1D) Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Type 1 Diabetes (T1D) Sales Market Share in Value by Type in 2025 Figure 19. Latin America Type 1 Diabetes (T1D) Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Type 1 Diabetes (T1D) Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Type 1 Diabetes (T1D) Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Type 1 Diabetes (T1D) Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Type 1 Diabetes (T1D) Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Children Image Figure 26. Global Children Sales YoY Growth (2021-2032) & (k units) Figure 27. Adults Image Figure 28. Global Adults Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Type 1 Diabetes (T1D) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Type 1 Diabetes (T1D) Market Share by Application 2025 VS 2032 Figure 31. North America Type 1 Diabetes (T1D) Sales Market Share in Volume by Application in 2025 Figure 32. North America Type 1 Diabetes (T1D) Sales Market Share in Value by Application in 2025 Figure 33. Europe Type 1 Diabetes (T1D) Sales Market Share in Volume by Application in 2025 Figure 34. Europe Type 1 Diabetes (T1D) Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Type 1 Diabetes (T1D) Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Type 1 Diabetes (T1D) Sales Market Share in Value by Application in 2025 Figure 37. Latin America Type 1 Diabetes (T1D) Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Type 1 Diabetes (T1D) Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Type 1 Diabetes (T1D) Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Type 1 Diabetes (T1D) Sales Market Share in Value by Application in 2025 Figure 41. North America Type 1 Diabetes (T1D) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Type 1 Diabetes (T1D) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Type 1 Diabetes (T1D) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Type 1 Diabetes (T1D) Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Type 1 Diabetes (T1D) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Type 1 Diabetes (T1D) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Type 1 Diabetes (T1D) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Type 1 Diabetes (T1D) Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Type 1 Diabetes (T1D) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Type 1 Diabetes (T1D) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Type 1 Diabetes (T1D) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Type 1 Diabetes (T1D) Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Type 1 Diabetes (T1D) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Type 1 Diabetes (T1D) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Type 1 Diabetes (T1D) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Type 1 Diabetes (T1D) Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Type 1 Diabetes (T1D) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Type 1 Diabetes (T1D) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Type 1 Diabetes (T1D) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Type 1 Diabetes (T1D) Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Type 1 Diabetes (T1D) Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Type 1 Diabetes (T1D) Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Long Acting Insulin Analogs
  • Premix Insulin Analogs
  • Rapid Acting Insulin Analogs
Applications
  • Children
  • Adults
Companies covered
  • Janssen
  • Sanofi
  • Sanofi
  • Novo Nordisk
  • Merck
  • Eli Lilly
  • Samsung Bioepis
  • Lexicon
  • Bristol-Myers Squibb
  • Boehringer Ingelheim
  • Biocon
  • Astellas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Type 1 Diabetes (T1D) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Type 1 Diabetes (T1D) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Type 1 Diabetes (T1D) Market by Type
  6. 1.3.1 Long Acting Insulin Analogs
  7. 1.3.2 Premix Insulin Analogs
  8. 1.3.3 Rapid Acting Insulin Analogs
  9. 1.4 Global Type 1 Diabetes (T1D) Market Size by Type
  10. 1.4.1 Global Type 1 Diabetes (T1D) Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Type 1 Diabetes (T1D) Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Type 1 Diabetes (T1D) Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Type 1 Diabetes (T1D) Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Type 1 Diabetes (T1D) Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Type 1 Diabetes (T1D) Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Type 1 Diabetes (T1D) Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Type 1 Diabetes (T1D) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Type 1 Diabetes (T1D) Industry Trends
  2. 2.2 Type 1 Diabetes (T1D) Industry Drivers
  3. 2.3 Type 1 Diabetes (T1D) Industry Opportunities and Challenges
  4. 2.4 Type 1 Diabetes (T1D) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Type 1 Diabetes (T1D) Revenue (2021-2026)
  2. 3.2 Global Top Players by Type 1 Diabetes (T1D) Sales (2021-2026)
  3. 3.3 Global Top Players by Type 1 Diabetes (T1D) Price (2021-2026)
  4. 3.4 Global Type 1 Diabetes (T1D) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Type 1 Diabetes (T1D) Major Company Production Sites & Headquarters
  6. 3.6 Global Type 1 Diabetes (T1D) Company, Product Type & Application
  7. 3.7 Global Type 1 Diabetes (T1D) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Type 1 Diabetes (T1D) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Type 1 Diabetes (T1D) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Type 1 Diabetes (T1D) Tier 1, Tier 2, and Tier 3
4 Type 1 Diabetes (T1D) Regional Status and Outlook
  1. 4.1 Global Type 1 Diabetes (T1D) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Type 1 Diabetes (T1D) Historic Market Size by Region
  3. 4.2.1 Global Type 1 Diabetes (T1D) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Type 1 Diabetes (T1D) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Type 1 Diabetes (T1D) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Type 1 Diabetes (T1D) Forecasted Market Size by Region
  7. 4.3.1 Global Type 1 Diabetes (T1D) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Type 1 Diabetes (T1D) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Type 1 Diabetes (T1D) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Type 1 Diabetes (T1D) by Application
  1. 5.1 Type 1 Diabetes (T1D) Market by Application
  2. 5.1.1 Children
  3. 5.1.2 Adults
  4. 5.2 Global Type 1 Diabetes (T1D) Market Size by Application
  5. 5.2.1 Global Type 1 Diabetes (T1D) Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Type 1 Diabetes (T1D) Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Type 1 Diabetes (T1D) Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Type 1 Diabetes (T1D) Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Type 1 Diabetes (T1D) Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Type 1 Diabetes (T1D) Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Type 1 Diabetes (T1D) Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Type 1 Diabetes (T1D) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Janssen
  2. 6.1.1 Janssen Company Information
  3. 6.1.2 Janssen Business Overview
  4. 6.1.3 Janssen Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Janssen Type 1 Diabetes (T1D) Product Portfolio
  6. 6.1.5 Janssen Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Type 1 Diabetes (T1D) Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Type 1 Diabetes (T1D) Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Novo Nordisk
  20. 6.4.1 Novo Nordisk Company Information
  21. 6.4.2 Novo Nordisk Business Overview
  22. 6.4.3 Novo Nordisk Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novo Nordisk Type 1 Diabetes (T1D) Product Portfolio
  24. 6.4.5 Novo Nordisk Recent Developments
  25. 6.5 Merck
  26. 6.5.1 Merck Company Information
  27. 6.5.2 Merck Business Overview
  28. 6.5.3 Merck Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merck Type 1 Diabetes (T1D) Product Portfolio
  30. 6.5.5 Merck Recent Developments
  31. 6.6 Eli Lilly
  32. 6.6.1 Eli Lilly Company Information
  33. 6.6.2 Eli Lilly Business Overview
  34. 6.6.3 Eli Lilly Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Eli Lilly Type 1 Diabetes (T1D) Product Portfolio
  36. 6.6.5 Eli Lilly Recent Developments
  37. 6.7 Samsung Bioepis
  38. 6.7.1 Samsung Bioepis Company Information
  39. 6.7.2 Samsung Bioepis Business Overview
  40. 6.7.3 Samsung Bioepis Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Samsung Bioepis Type 1 Diabetes (T1D) Product Portfolio
  42. 6.7.5 Samsung Bioepis Recent Developments
  43. 6.8 Lexicon
  44. 6.8.1 Lexicon Company Information
  45. 6.8.2 Lexicon Business Overview
  46. 6.8.3 Lexicon Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Lexicon Type 1 Diabetes (T1D) Product Portfolio
  48. 6.8.5 Lexicon Recent Developments
  49. 6.9 Bristol-Myers Squibb
  50. 6.9.1 Bristol-Myers Squibb Company Information
  51. 6.9.2 Bristol-Myers Squibb Business Overview
  52. 6.9.3 Bristol-Myers Squibb Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Bristol-Myers Squibb Type 1 Diabetes (T1D) Product Portfolio
  54. 6.9.5 Bristol-Myers Squibb Recent Developments
  55. 6.10 Boehringer Ingelheim
  56. 6.10.1 Boehringer Ingelheim Company Information
  57. 6.10.2 Boehringer Ingelheim Business Overview
  58. 6.10.3 Boehringer Ingelheim Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Boehringer Ingelheim Type 1 Diabetes (T1D) Product Portfolio
  60. 6.10.5 Boehringer Ingelheim Recent Developments
  61. 6.11 Biocon
  62. 6.11.1 Biocon Company Information
  63. 6.11.2 Biocon Business Overview
  64. 6.11.3 Biocon Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Biocon Type 1 Diabetes (T1D) Product Portfolio
  66. 6.11.5 Biocon Recent Developments
  67. 6.12 Astellas
  68. 6.12.1 Astellas Company Information
  69. 6.12.2 Astellas Business Overview
  70. 6.12.3 Astellas Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Astellas Type 1 Diabetes (T1D) Product Portfolio
  72. 6.12.5 Astellas Recent Developments
7 North America by Country
  1. 7.1 North America Type 1 Diabetes (T1D) Sales by Country
  2. 7.1.1 North America Type 1 Diabetes (T1D) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Type 1 Diabetes (T1D) Sales by Country (2021-2026)
  4. 7.1.3 North America Type 1 Diabetes (T1D) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Type 1 Diabetes (T1D) Market Size by Country
  6. 7.2.1 North America Type 1 Diabetes (T1D) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Type 1 Diabetes (T1D) Market Size by Country (2021-2026)
  8. 7.2.3 North America Type 1 Diabetes (T1D) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Type 1 Diabetes (T1D) Sales by Country
  2. 8.1.1 Europe Type 1 Diabetes (T1D) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Type 1 Diabetes (T1D) Sales by Country (2021-2026)
  4. 8.1.3 Europe Type 1 Diabetes (T1D) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Type 1 Diabetes (T1D) Market Size by Country
  6. 8.2.1 Europe Type 1 Diabetes (T1D) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Type 1 Diabetes (T1D) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Type 1 Diabetes (T1D) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Type 1 Diabetes (T1D) Sales by Country
  2. 9.1.1 Asia-Pacific Type 1 Diabetes (T1D) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Type 1 Diabetes (T1D) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Type 1 Diabetes (T1D) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Type 1 Diabetes (T1D) Market Size by Country
  6. 9.2.1 Asia-Pacific Type 1 Diabetes (T1D) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Type 1 Diabetes (T1D) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Type 1 Diabetes (T1D) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Type 1 Diabetes (T1D) Sales by Country
  2. 10.1.1 South America Type 1 Diabetes (T1D) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Type 1 Diabetes (T1D) Sales by Country (2021-2026)
  4. 10.1.3 South America Type 1 Diabetes (T1D) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Type 1 Diabetes (T1D) Market Size by Country
  6. 10.2.1 South America Type 1 Diabetes (T1D) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Type 1 Diabetes (T1D) Market Size by Country (2021-2026)
  8. 10.2.3 South America Type 1 Diabetes (T1D) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Type 1 Diabetes (T1D) Sales by Country
  2. 11.1.1 Middle East and Africa Type 1 Diabetes (T1D) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Type 1 Diabetes (T1D) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Type 1 Diabetes (T1D) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Type 1 Diabetes (T1D) Market Size by Country
  6. 11.2.1 Middle East and Africa Type 1 Diabetes (T1D) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Type 1 Diabetes (T1D) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Type 1 Diabetes (T1D) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Type 1 Diabetes (T1D) Value Chain Analysis
  2. 12.1.1 Type 1 Diabetes (T1D) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Type 1 Diabetes (T1D) Production Mode & Process
  7. 12.2 Type 1 Diabetes (T1D) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Type 1 Diabetes (T1D) Distributors
  10. 12.2.3 Type 1 Diabetes (T1D) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst